Tabernero, J., Lenz, H., Siena, S., Sobrero, A., Falcone, A., Ychou, M., . . . Van Cutsem, E. (2015). Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial. Lancet Oncol.
Chicago Style CitationTabernero, Josep, et al. "Analysis of Circulating DNA and Protein Biomarkers to Predict the Clinical Activity of Regorafenib and Assess Prognosis in Patients With Metastatic Colorectal Cancer: A Retrospective, Exploratory Analysis of the CORRECT Trial." Lancet Oncol 2015.
Cita MLATabernero, Josep, et al. "Analysis of Circulating DNA and Protein Biomarkers to Predict the Clinical Activity of Regorafenib and Assess Prognosis in Patients With Metastatic Colorectal Cancer: A Retrospective, Exploratory Analysis of the CORRECT Trial." Lancet Oncol 2015.